Back to
Avoro Capital Advisors LLC
CUE6 quarters
Position history for
Avoro Capital Advisors LLC's holdings in CUE BIOPHARMA INC
No. Avoro Capital Advisors exited its CUE (Cue Biopharma) position in Q1 2021. Its Q4 2020 13F listed 452,500 shares worth $5.7M. Avoro Capital Advisors first reported CUE in Q4 2019 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$29.7M
Total Shares Change
-1.9M
Quarter-by-Quarter History
Other major holders of CUE: STATE STREET CORP